Company Overview of Burrill Life Sciences Capital Fund III, L.P.
Burrill Life Sciences Capital Fund III, L.P. specializes in seed, early stage, late stage, and mezzanine investments. It prefers to invest in biotechnology, life sciences, pharmaceuticals, diagnostics, devices, human healthcare, wellness and nutraceuticals, agbio, and industrial biotechnology sectors. The fund invests globally. It invests between $1 million and $20 million on an average in its portfolio companies.
One Maritime Plaza
San Francisco, CA 94111
Founded in 2005
Key Executives for Burrill Life Sciences Capital Fund III, L.P.
Similar Private Companies By Industry
|@Visory LLC||United States|
|1 Road Partners LLC||United States|
|11T Partners, LLC||United States|
|13D Research (USVI) LLC.||United States|
|1509225 Ontario, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|Bloomberg L.P.||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
To contact Burrill Life Sciences Capital Fund III, L.P., please visit venture.burrillandco.com/funds-23-Burrill_Life_Sciences_Capital_Fund_III_LP__Active.html. Company data is provided by Capital IQ. Please use this form to report any data issues.